Navigation Links
MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
Date:2/28/2011

lopment.  In the clinical trial, patients administered LEVADEX themselves using the proprietary TEMPO® inhaler.  LEVADEX contains a novel formulation of dihydroergotamine (DHE).  LEVADEX was evaluated in the efficacy portion of FREEDOM-301, MAP Pharmaceuticals' Phase 3 pivotal trial, which included 395 patients in the LEVADEX arm and 397 patients in the placebo arm.  In the Phase 3 trial, patients taking LEVADEX therapy had statistically significant improvement at two hours compared to patients on placebo for all four co-primary endpoints:

  • Pain relief: 58.7 percent of patients who received LEVADEX compared with 34.5 percent for placebo (p<0.0001);
  • Phonophobia free: 52.9 percent of patients who received LEVADEX compared with 33.8 percent for placebo (p<0.0001);
  • Photophobia free: 46.6 percent of patients who received LEVADEX compared with 27.2 percent for placebo (p<0.0001); and
  • Nausea free: 67.1 percent of patients who received LEVADEX compared with 58.7 percent for placebo (p=0.02).

  • The most common adverse event reported was medication aftertaste at six percent versus two percent for placebo. The next most common adverse event was nausea at five percent compared with two percent for placebo.  There were no decreases in lung function, as measured by spirometry, between the active and placebo groups. 

    About Migraine Common symptoms of migraine include recurrent headaches, nausea, vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to sound).  According to the National Headache Foundation, most migraines last between four and 24 hours, but some last as long as three days.  On average, migraine sufferers experience 1.5 migraine attacks monthly, although 25 percent of them experience one or more attacks weekly.  The economic burden of migraine remains substantial despite existing treatments, with the direct and indirect costs of migr
    '/>"/>

    SOURCE MAP Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
    2. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
    3. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
    4. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
    5. UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear
    6. JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement
    7. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
    8. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
    9. Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1
    10. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
    11. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... yesterday,s release of Center for Medicaid and Medicare services data ... to know: ... , As required ... Medicare and other government programs because it relies on competition ... benefits to enrollees. , Competition and rebates have been ...
    (Date:5/1/2015)... Corporation (NASDAQ: THOR ), a world leader in mechanical ... announced today that Marta Antonucci has joined Thoratec ... This new Europe -based position is responsible ... America , including Europe , ... , and reports directly to the Chief Executive Officer. Following the ...
    (Date:5/1/2015)... May 1, 2015  Legendary actor and director ... new PBAFacts campaign designed to educate and encourage patients ... about Pseudobulbar Affect (PBA) and to speak with their ... actor has the ability to cry and laugh on ... control experienced by people living with PBA episodes. ...
    Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
    ... Corporation ( www.generex.com ) (OTC Bulletin Board: ... Antigen Express, Inc. ( www.antigenexpress.com ), announced today that ... Henry M. Jackson Foundation for the Advancement of Military ... on-going Phase II clinical study of Antigen,s AE37 novel ...
    ... FDLI,s Food and Drug Policy Forum (Volume 1, Number 2), ... important issue of genetically modified organisms (GMOs). In ... website ( www.fdli.org ), Ross H. Pifer, Director, and Richard ... and Reference Center at Penn State University,s Dickinson School of ...
    Cached Medicine Technology:Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 2Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 3Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 4Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 5FDLI's Food and Drug Policy Forum Examines European GMO Rules 2
    (Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
    (Date:5/1/2015)... 2015 Royal River Natural Foods, a ... on a new study that found two natural nutrients, ... improved physical function as well as standard drug treatment ... the knee. , The report is part of the ... Being® ,” which Royal River Natural Foods publishes for ...
    (Date:5/1/2015)... TROY Healthcare Solutions is proud to ... Group (RUG) Conference in Atlanta, GA from May 6 ... Conference provides a forum for client-to-client presentations, continuing education ... of electronic medical record operations, as well as showcasing ... In addition to sponsoring the event, TROY Healthcare Solutions ...
    (Date:5/1/2015)... Hope For The Warriors® thanks All ... The Warriors® and military families. All American Ford presented ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... collected and matched small autograph fee from fans and ...
    (Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
    Breaking Medicine News(10 mins):Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3
    ... death improves cancer therapy efficacy , Individuals ... aggressive types of brain tumor, have an extremely ... a group of proteins known as receptor tyrosine ... with GBM, these RTK inhibitors have met with ...
    ... is a time of great excitement and anticipation. It ... women with type 1 or type 2 diabetes. Pregnancy ... But a new, easy-to-read booklet has information to help ... For Women with Diabetes: Your Guide to Pregnancy is ...
    ... neurodegenerative diseases, study says , , FRIDAY, Aug. ... human brain has the ability to grow new neurons, ... , The study included nine people with multiple sclerosis ... In MS, the immune system destroys the myelin sheaths ...
    ... LLC announced today it,has completed its previously announced ... Corporation (OTC Bulletin Board: IMMC) and its,wholly-owned subsidiaries., ... inventory,and clinical data as well as all technologies ... to automate the detection and enumeration,of circulating tumor ...
    ... BEACH, Calif., Aug. 1 Nationwide,Health Properties, Inc. (NYSE: ... declared a $0.44 per share dividend on the company,s ... to shareholders of record on August,15, 2008., In ... share,dividend on the Series B cumulative convertible preferred stock ...
    ... 43 National Chains; 6 Receive an ,F, NEW ... likely to,make your children fat? A year-long study of ... fast-food and sit-down,chain restaurants, according to the authors of ... David Zinczenko and Matt Goulding calculated,calories, fat (trans- and ...
    Cached Medicine News:Health News:JCI online early table of contents: Aug. 1, 2008 2Health News:JCI online early table of contents: Aug. 1, 2008 3Health News:JCI online early table of contents: Aug. 1, 2008 4Health News:JCI online early table of contents: Aug. 1, 2008 5Health News:JCI online early table of contents: Aug. 1, 2008 6Health News:JCI online early table of contents: Aug. 1, 2008 7Health News:Neurons Can Re-Grow in Some MS Lesions 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:America's Worst Restaurants for Kids Revealed 2Health News:America's Worst Restaurants for Kids Revealed 3Health News:America's Worst Restaurants for Kids Revealed 4Health News:America's Worst Restaurants for Kids Revealed 5
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: